Literature DB >> 21429042

Radio-guided surgery: advantages of a new portable γ-camera (Sentinella) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies.

I Stoffels1, T Poeppel, C Boy, S Mueller, F Wichmann, J Dissemond, D Schadendorf, S Rosenbaum-Krumme, J Klode.   

Abstract

BACKGROUND: The histological status of the sentinel lymph node (SLN) is one of the most relevant prognostic factors for the overall survival of patients with cutaneous malignancies, independent of tumour depth of the primary tumour.
OBJECTIVES: Our study seeks to evaluate the reliability and medical benefit of SLN excision (SLNE) performed with a portable γ-camera for intraoperative real time imaging of SLN.
METHODS: Therefore our study compares the visualization of SLN performed with preoperative lymphoscintigraphy and preoperative SPECT/CT with the intraoperative real time imaging of SLN performed with a new portable γ-camera (Sentinella) in 60 patients who were treated with a SLNE for early stage melanoma (n = 38), high risk cutaneous squamous cell carcinoma (n = 16), Merkel cell carcinoma (n = 4), sebaceous gland carcinoma (n = 1), and sweat glands carcinoma or porocarcinoma (n = 1).
RESULTS: Sixty patients were enrolled in this study. The portable γ-camera visualized all 126 preoperatively identified SLN. 23 additional SLN (15.4%) in 15 patients were only identified using the portable γ-camera. Two of these additional SLN showed metastatic involvement.
CONCLUSION: The portable γ-camera is an innovative imaging technique, reliable and providing additional information in the detection of SLN. Therefore SLNE with intraoperative γ-camera use is an attractive option to improve the detection of SLN in cutaneous malignancies and could help to reduce false negative SLN results.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21429042     DOI: 10.1111/j.1468-3083.2011.04057.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

Review 2.  Melanoma and nuclear medicine.

Authors:  Andrés Perissinotti; Sergi Vidal-Sicart; Omgo Nieweg; Renato Valdés Olmos
Journal:  Melanoma Manag       Date:  2014-09-05

3.  Development and characterization of a round hand-held silicon photomultiplier based gamma camera for intraoperative imaging.

Authors:  Kosta Popovic; Jack E McKisson; Brian Kross; Seungjoon Lee; John McKisson; Andrew G Weisenberger; James Proffitt; Alexander Stolin; Stan Majewski; Mark B Williams
Journal:  IEEE Trans Nucl Sci       Date:  2014-05-20       Impact factor: 1.679

Review 4.  Melanoma & nuclear medicine: new insights & advances.

Authors:  Andrés Perissinotti; Daphne Dd Rietbergen; Sergi Vidal-Sicart; Ana A Riera; Renato A Valdés Olmos
Journal:  Melanoma Manag       Date:  2018-06-28

5.  Fluorescent lectins for local in vivo visualization of peripheral nerves.

Authors:  Gijs Hendrik KleinJan; Tessa Buckle; Danny Michel van Willigen; Matthias Nathanaël van Oosterom; Silvia Johara Spa; Harmen Egbert Kloosterboer; Fijs Willem Bernhard van Leeuwen
Journal:  Molecules       Date:  2014-07-08       Impact factor: 4.411

6.  Fluorescence background quenching as a means to increase Signal to Background ratio - a proof of concept during Nerve Imaging.

Authors:  Tessa Buckle; Steffen van der Wal; Danny M van Willigen; Germaine Aalderink; Gijs H KleinJan; Fijs W B van Leeuwen
Journal:  Theranostics       Date:  2020-08-06       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.